WPG Advisers’s Medpace MEDP Stock Holding History

WPG Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3	Closed	-$914	–	1473
2025 Q1	$914	Hold	3	–	–	﹤0.01%	1268
2024 Q4	$997	Buy	+3	New	+$1.02K	﹤0.01%	1227

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

WPG Advisers's MEDP Position: Q2 2025 in Review

WPG Advisers sold out of Medpace (MEDP) in Q2 2025, closing a stake of 3 shares — an estimated $914 sold.

WPG Advisers first reported a position in MEDP in Q4 2024 and held it in 2 quarters. The position peaked at $997 in Q4 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

WPG Advisers reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
WPG Advisers sold 3 Medpace shares in Q2 2025, an estimated $914.
WPG Advisers first reported a position in Medpace in Q4 2024 and held it in 2 quarters.
WPG Advisers's Medpace position peaked at $997 in Q4 2024.
602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on WPG Advisers's 13F filing for Q2 2025, filed 11 Aug 2025.